Treatment of Relapsed/Refractory Myeloma (excluding T-cell redirection therapy)
Selinexor combined with bortezomib, thalidomide, and dexamethasone in relapsed/refractory multiple myeloma patients who have undergone severe treatment: a single-arm, multicenter, prospective study
Jingsong He, Doctor
Physician
the First Hospital of Zhejiang University School of Medicine, China (People's Republic)